{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:38:14Z","timestamp":1794062294520,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,22]]},"DOI":"10.7759\/cureus.13495","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T18:38:06Z","timestamp":1614019086000},"source":"Crossref","is-referenced-by-count":9,"title":["CD26\/Dipeptidyl Peptidase IV and Its Multiple Biological Functions"],"prefix":"10.7759","author":[{"given":"Kelsey","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ohnuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikao","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam H","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2174\/138955707780059853","article-title":"CD26\/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders","volume":"7","author":"Thompson MA","year":"2007","unstructured":"Thompson MA, Ohnuma K, Abe M, Morimoto C, Dang NH. CD26\/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders. Mini Rev Med Chem. 2007, 7:253-273. 10.2174\/138955707780059853","journal-title":"Mini Rev Med Chem"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.2174\/1573394713666170907160734","article-title":"Current and emerging therapy for malignant pleural mesothelioma: focus on CD26\/dipeptidyl peptidase IV as a therapeutic target","volume":"13","author":"Doonan BP","year":"2017","unstructured":"Doonan BP, Ohnuma K, Dang LH, Morimoto C, Dang NH. Current and emerging therapy for malignant pleural mesothelioma: focus on CD26\/dipeptidyl peptidase IV as a therapeutic target. Curr Cancer Ther Rev. 2017, 13:76-88.","journal-title":"Curr Cancer Ther Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.001897","article-title":"Middle east respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells","volume":"293","author":"Chu H","year":"2018","unstructured":"Chu H, Chan CM, Zhang X, et al.. Middle east respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells. J Biol Chem. 2018, 293:11709-11726. 10.1074\/jbc.RA118.001897","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1619109114","article-title":"Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice","volume":"114","author":"Li K","year":"2017","unstructured":"Li K, Wohlford-Lenane CL, Channappanavar R, et al.. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc Natl Acad Sci U S A. 2017, 114:3119-3128. 10.1073\/pnas.1619109114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","article-title":"1F7, a novel cell surface molecule, involved in helper function of CD4 cells","volume":"143","author":"Morimoto C","year":"1990","unstructured":"Morimoto C, Torimoto Y, Levinson G, et al.. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J Immunol. 1990, 143:3430-3439.","journal-title":"J Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(90)90061-u","article-title":"FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation","volume":"125","author":"Dang NH","year":"1990","unstructured":"Dang NH, Hafler DA, Schlossman SF, Breitmeyer JB. FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation. Cell Immunol. 1990, 125:42-57. 10.1016\/0008-8749(90)90061-u","journal-title":"Cell Immunol"},{"key":"ref7","article-title":"Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways","volume":"144","author":"Dang NH","year":"1990","unstructured":"Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. J Immunol. 1990, 144:4092-4100.","journal-title":"J Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.2.649","article-title":"Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family","volume":"172","author":"Dang NH","year":"1990","unstructured":"Dang NH, Torimoto Y, Schlossman SF, Morimoto C. Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family. J Exp Med. 1990, 172:649-652. 10.1084\/jem.172.2.649","journal-title":"J Exp Med"},{"key":"ref9","article-title":"1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation","volume":"147","author":"Dang NH","year":"1991","unstructured":"Dang NH, Torimoto Y, Shimamura K, et al.. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J Immunol. 1991, 147:2825-2832.","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0161-5890(92)90099-j","article-title":"Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies","volume":"29","author":"Torimoto Y","year":"1992","unstructured":"Torimoto Y, Dang NH, Tanaka T, Prado C, Schlossman SF, Morimoto C. Biochemical characterization of CD26 (dipeptidyl peptidase IV): functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol Immunol. 1992, 29:183-192. 10.1016\/0161-5890(92)90099-j","journal-title":"Mol Immunol"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.147.8.2514","article-title":"Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes","volume":"147","author":"Torimoto Y","year":"1991","unstructured":"Torimoto Y, Dang NH, Vivier E, Tanaka T, Schlossman SF, Morimoto C. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes. J Immunol. 1991, 147:2514-2517.","journal-title":"J Immunol"},{"key":"ref12","article-title":"Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation","volume":"145","author":"Dang NH","year":"1990","unstructured":"Dang NH, Torimoto Y, Sugita K, et al.. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J Immunol. 1990, 145:3963-3971.","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12378","article-title":"Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody","volume":"162","author":"Hatano R","year":"2013","unstructured":"Hatano R, Ohnuma K, Yamamoto J, Dang NH, Yamada T, Morimoto C. Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody. Br J Haematol. 2013, 162:263-277. 10.1111\/bjh.12378","journal-title":"Br J Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402785","article-title":"Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes","volume":"194","author":"Ohnuma K","year":"2015","unstructured":"Ohnuma K, Hatano R, Aune TM, et al.. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes. J Immunol. 2015, 194:3697-3712. 10.4049\/jimmunol.1402785","journal-title":"J Immunol"},{"key":"ref15","article-title":"Sitagliptin inhibits extracellular matrix accumulation and proliferation in lung fibroblasts","volume":"26","author":"Liu X","year":"2020","unstructured":"Liu X, Zhang T, Zhang C. Sitagliptin inhibits extracellular matrix accumulation and proliferation in lung fibroblasts. Med Sci Monit. 2020, 26:e922644.","journal-title":"Med Sci Monit"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027372","article-title":"Dipeptidyl peptidase 4 inhibition for prophylaxis of acute graft-versus-host disease","volume":"384","author":"Farag SS","year":"2021","unstructured":"Farag SS, Abu Zaid M, Schwartz JE, et al.. Dipeptidyl peptidase 4 inhibition for prophylaxis of acute graft-versus-host disease. N Engl J Med. 2021, 384:11-19. 10.1056\/NEJMoa2027372","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2010.08.112","article-title":"Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines","volume":"401","author":"Takasawa W","year":"2010","unstructured":"Takasawa W, Ohnuma K, Hatano R, Endo Y, Dang NH, Morimoto C. Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines. Biochem Biophys Res Commun. 2010, 401:7-12. 10.1016\/j.bbrc.2010.08.112","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1338","article-title":"Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice","volume":"60","author":"Shirakawa J","year":"2011","unstructured":"Shirakawa J, Fujii H, Ohnuma K, et al.. Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice. Diabetes. 2011, 60:1246-1257. 10.2337\/db10-1338","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.2.194","article-title":"Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis","volume":"298","author":"Amori RE","year":"2007","unstructured":"Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA. 2007, 298:194-206. 10.1001\/jama.298.2.194","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.2741\/4671","article-title":"A novel role for CD26\/dipeptidyl peptidase IV as a therapeutic target","volume":"23","author":"Ohnuma K","year":"2018","unstructured":"Ohnuma K, Hatano R, Komiya E, et al.. A novel role for CD26\/dipeptidyl peptidase IV as a therapeutic target. Front Biosci (Landmark Ed). 2018, 23:1754-1779.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601253","article-title":"CD26\/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors","volume":"89","author":"Sato K","year":"2003","unstructured":"Sato K, Aytac U, Yamochi T, et al.. CD26\/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors. Br J Cancer. 2003, 89:1366-1374. 10.1038\/sj.bjc.6601253","journal-title":"Br J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600791","article-title":"Effect of CD26\/dipeptidyl peptidase IV on Jurkat sensitivity to G2\/M arrest induced by topoisomerase II inhibitors","volume":"88","author":"Aytac U","year":"2003","unstructured":"Aytac U, Sato K, Yamochi T, et al.. Effect of CD26\/dipeptidyl peptidase IV on Jurkat sensitivity to G2\/M arrest induced by topoisomerase II inhibitors. Br J Cancer. 2003, 88:455-462. 10.1038\/sj.bjc.6600791","journal-title":"Br J Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2611","article-title":"Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26\/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin","volume":"65","author":"Yamochi T","year":"2005","unstructured":"Yamochi T, Yamochi T, Aytac U, et al.. Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26\/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin. Cancer Res. 2005, 65:1973-1983. 10.1158\/0008-5472.CAN-04-2611","journal-title":"Cancer Res"},{"key":"ref24","article-title":"CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma","volume":"18","author":"Aoe K","year":"2012","unstructured":"Aoe K, Amatya VJ, Fujimoto N, et al.. CD26 overexpression is associated with prolonged survival and enhanced chemosensitivity in malignant pleural mesothelioma. Clin Cancer Res. 2012, 18:1447-56.","journal-title":"Clin Cancer Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.62","article-title":"First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers","volume":"116","author":"Angevin E","year":"2017","unstructured":"Angevin E, Isambert N, Trillet-Lenoir V, et al.. First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers. Br J Cancer. 2017, 116:1126-1134. 10.1038\/bjc.2017.62","journal-title":"Br J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.09.010","article-title":"Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma","volume":"137","author":"Takeda M","year":"2019","unstructured":"Takeda M, Ohe Y, Horinouchi H, et al.. Phase I study of YS110, a recombinant humanized monoclonal antibody to CD26, in Japanese patients with advanced malignant pleural mesothelioma. Lung Cancer. 2019, 137:64-70. 10.1016\/j.lungcan.2019.09.010","journal-title":"Lung Cancer"},{"key":"ref27","article-title":"Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters","volume":"18","author":"Lu Z","year":"2013","unstructured":"Lu Z, Qi L, Bo XJ, Liu GD, Wang JM, Li G. Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters. J Res Med Sci. 2013, 18:647-652.","journal-title":"J Res Med Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00405","article-title":"Impact of DPP4 inhibitors in survival of patients with prostate, pancreas, and breast cancer","volume":"10","author":"Shah C","year":"2020","unstructured":"Shah C, Hong YR, Bishnoi R, et al.. Impact of DPP4 inhibitors in survival of patients with prostate, pancreas, and breast cancer. Front Oncol. 2020, 10:405-2020. 10.3389\/fonc.2020.00405","journal-title":"Front Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1852","article-title":"Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway","volume":"65","author":"Wesley UV","year":"2005","unstructured":"Wesley UV, McGroarty M, Homoyouni A. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res. 2005, 65:1325-1334. 10.1158\/0008-5472.CAN-04-1852","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-008-9188-9","article-title":"CD26\/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1\/CXCL12","volume":"25","author":"Sun YX","year":"2008","unstructured":"Sun YX, Pedersen EA, Shiozawa Y, et al.. CD26\/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1\/CXCL12. Clin Exp Metastasis. 2008, 25:765-776. 10.1007\/s10585-008-9188-9","journal-title":"Clin Exp Metastasis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-0687","article-title":"Downregulation of dipeptidyl peptidase 4 accelerates progression to castration-resistant prostate cancer","volume":"78","author":"Russo JW","year":"2018","unstructured":"Russo JW, Gao C, Bhasin SS, et al.. Downregulation of dipeptidyl peptidase 4 accelerates progression to castration-resistant prostate cancer. Cancer Res. 2018, 78:6354-6362. 10.1158\/0008-5472.CAN-18-0687","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M114.038836","article-title":"Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer","volume":"13","author":"Nazarian A","year":"2014","unstructured":"Nazarian A, Lawlor K, Yi SS, et al.. Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer. Mol Cell Proteomics. 2014, 13:3082-3096. 10.1074\/mcp.M114.038836","journal-title":"Mol Cell Proteomics"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1410","article-title":"Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer","volume":"83","author":"Cordero OJ","year":"2000","unstructured":"Cordero OJ, Ayude D, Nogueira M, Rodr\u00edguez-Berrocal FJ, de la Cadena MP. Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer. Br J Cancer. 2000, 83:1139-1146. 10.1054\/bjoc.2000.1410","journal-title":"Br J Cancer"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-333","article-title":"Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas","volume":"10","author":"De Chiara L","year":"2010","unstructured":"De Chiara L, Rodr\u00edguez-Pi\u00f1eiro AM, Rodr\u00edguez-Berrocal FJ, Cordero OJ, Mart\u00ednez-Ares D, de la Cadena MP. Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas. BMC Cancer. 2010, 10:333-2010. 10.1186\/1471-2407-10-333","journal-title":"BMC Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119436","article-title":"Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis","volume":"10","author":"Larrinaga G","year":"2015","unstructured":"Larrinaga G, Perez I, Sanz B, et al.. Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis. PLoS One. 2015, 10:0119436-2015. 10.1371\/journal.pone.0119436","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgz009","article-title":"The CD26\/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity","volume":"40","author":"Jang JH","year":"2019","unstructured":"Jang JH, Janker F, De Meester I, et al.. The CD26\/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity. Carcinogenesis. 2019, 40:324-334. 10.1093\/carcin\/bgz009","journal-title":"Carcinogenesis"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2010.04.001","article-title":"A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer","volume":"6","author":"Pang R","year":"2010","unstructured":"Pang R, Law WL, Chu AC, et al.. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell. 2010, 6:603-615. 10.1016\/j.stem.2010.04.001","journal-title":"Cell Stem Cell"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098582","article-title":"Prognostic significance of CD26 in patients with colorectal cancer","volume":"9","author":"Lam CSC","year":"2014","unstructured":"Lam CSC, Cheung AHK, Wong SKM, et al.. Prognostic significance of CD26 in patients with colorectal cancer. PLoS One. 2014, 9:98582-2014. 10.1371\/journal.pone.0098582","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18061106","article-title":"Emergence of CD26+ cancer stem cells with metastatic properties in colorectal carcinogenesis","volume":"18","author":"Cheung AH","year":"2017","unstructured":"Cheung AH, Iyer DN, Lam CS, et al.. Emergence of CD26+ cancer stem cells with metastatic properties in colorectal carcinogenesis. Int J Mol Sci. 2017, 18:1106-2017. 10.3390\/ijms18061106","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1993.tb01199.x","article-title":"Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma","volume":"23","author":"Asada Y","year":"1993","unstructured":"Asada Y, Aratake Y, Kotani T, Marutsuka K, Araki Y, Ohtaki S, Sumiyoshi A. Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma. Histopathology. 1993, 23:265-270. 10.1111\/j.1365-2559.1993.tb01199.x","journal-title":"Histopathology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2278","article-title":"Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: a surveillance epidemiology and endpoint research medicare study","volume":"8","author":"Bishnoi R","year":"2019","unstructured":"Bishnoi R, Hong YR, Shah C, et al.. Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: a surveillance epidemiology and endpoint research medicare study. Cancer Med. 2019, 8:3918-3927. 10.1002\/cam4.2278","journal-title":"Cancer Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04365.x","article-title":"T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition","volume":"121","author":"Dang NH","year":"2003","unstructured":"Dang NH, Aytac U, Sato K, et al.. T-large granular lymphocyte lymphoproliferative disorder: expression of CD26 as a marker of clinically aggressive disease and characterization of marrow inhibition. Br J Haematol. 2003, 121:857-865. 10.1046\/j.1365-2141.2003.04365.x","journal-title":"Br J Haematol"},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V86.12.4617.bloodjournal86124617","article-title":"The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas\/leukemias","volume":"86","author":"Carbone A","year":"1995","unstructured":"Carbone A, Gloghini A, Zagonel V, et al.. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas\/leukemias. Blood. 1995, 86:4617-4626.","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV","article-title":"Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood","volume":"115","author":"Jones D","year":"2001","unstructured":"Jones D, Dang NH, Duvic M, Washington LT, Huh YO. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol. 2001, 115:885-892. 10.1309\/U1Y6-J4AG-5M4M-7AYV","journal-title":"Am J Clin Pathol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(11)80412-2","article-title":"Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells","volume":"192","author":"Reinhold D","year":"1994","unstructured":"Reinhold D, Bank U, B\u00fchling F, et al.. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Immunobiology. 1994, 192:121-136. 10.1016\/S0171-2985(11)80412-2","journal-title":"Immunobiology"},{"key":"ref46","article-title":"In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299","volume":"7","author":"Ho L","year":"2001","unstructured":"Ho L, Aytac U, Stephens LC, et al.. In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody 1F7 on human CD30+ anaplastic large cell T-cell lymphoma Karpas 299. Clin Cancer Res. 2001, 7:2031-2040.","journal-title":"Clin Cancer Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s12041-020-01217-7","article-title":"Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human","volume":"99","author":"Senapati S","year":"2020","unstructured":"Senapati S, Kumar S, Singh AK, et al.. Assessment of risk conferred by coding and regulatory variations of TMPRSS2 and CD26 in susceptibility to SARS-CoV-2 infection in human. J Genet. 2020, 99:53. 10.1007\/s12041-020-01217-7","journal-title":"J Genet"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13052","article-title":"COVID-19 and comorbidities: a role for dipeptidyl peptidase 4 (DPP4) in disease severity?","volume":"12","author":"Bassendine MF","year":"2020","unstructured":"Bassendine MF, Bridge SH, McCaughan GW, Gorrell MD. COVID-19 and comorbidities: a role for dipeptidyl peptidase 4 (DPP4) in disease severity?. J Diabetes. 2020, 12:649-658. 10.1111\/1753-0407.13052","journal-title":"J Diabetes"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/51979-cd26dipeptidyl-peptidase-iv-and-its-multiple-biological-functions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:09Z","timestamp":1707507249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/51979-cd26dipeptidyl-peptidase-iv-and-its-multiple-biological-functions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.13495","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,22]]}}}